- Home
- PGEN vs OIA Comparison
PGEN vs OIA Comparison
Compare PGEN & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- OIA
- Stock Information
- Founded
- PGEN 1998
- OIA 1988
- Country
- PGEN United States
- OIA United States
- Employees
- PGEN N/A
- OIA N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- OIA Finance Companies
- Sector
- PGEN Health Care
- OIA Finance
- Exchange
- PGEN Nasdaq
- OIA Nasdaq
- Market Cap
- PGEN 475.2M
- OIA 269.4M
- IPO Year
- PGEN N/A
- OIA N/A
- Fundamental
- Price
- PGEN $1.85
- OIA $5.74
- Analyst Decision
- PGEN Strong Buy
- OIA
- Analyst Count
- PGEN 3
- OIA 0
- Target Price
- PGEN $6.00
- OIA N/A
- AVG Volume (30 Days)
- PGEN 2.2M
- OIA 97.9K
- Earning Date
- PGEN 08-13-2025
- OIA 01-01-0001
- Dividend Yield
- PGEN N/A
- OIA 4.88%
- EPS Growth
- PGEN N/A
- OIA N/A
- EPS
- PGEN N/A
- OIA N/A
- Revenue
- PGEN $4,201,000.00
- OIA N/A
- Revenue This Year
- PGEN $158.57
- OIA N/A
- Revenue Next Year
- PGEN $1,086.91
- OIA N/A
- P/E Ratio
- PGEN N/A
- OIA N/A
- Revenue Growth
- PGEN N/A
- OIA N/A
- 52 Week Low
- PGEN $0.65
- OIA $4.93
- 52 Week High
- PGEN $2.17
- OIA $6.72
- Technical
- Relative Strength Index (RSI)
- PGEN 68.77
- OIA 49.55
- Support Level
- PGEN $1.56
- OIA $5.73
- Resistance Level
- PGEN $2.04
- OIA $5.83
- Average True Range (ATR)
- PGEN 0.11
- OIA 0.06
- MACD
- PGEN 0.04
- OIA 0.01
- Stochastic Oscillator
- PGEN 70.00
- OIA 52.50
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About OIA Invesco Municipal Income Opportunities Trust
Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.